AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19952830 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar trial (commercially available energy bar with 10 µg of 19‐norandrostenedione)
Number of subjects: 19
Study 18410769 — intervention group
Group type: EXPERIMENTAL
Intervention: aP (acellular pertussis vaccine)
Number of subjects: 121
Study 18410769 — intervention group
Group type: COMPARATOR
Intervention: HBV (hepatitis B vaccine)
Number of subjects: 121
Study 16337501 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ischemic chronic heart failure
Number of subjects: 161
Study 16337501 — intervention group
Group type: COMPARATOR
Intervention: Ischemic chronic heart failure
Number of subjects: 161
Study 11941952 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole plus trimebutine for 3 months (Group A)
Number of subjects: 69
Study 11941952 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole for 3 months (Group B)
Number of subjects: 69
Study 9853856 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanon
Number of subjects: 60
Study 9853856 — intervention group
Group type: EXPERIMENTAL
Intervention: Norplant
Number of subjects: 60
Study 7847131 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal tissue plasminogen activator (rTPA) 10 mg in 10 ml solution, additional 5-10 mg for severe intraventricular bleeding
Number of subjects: 224
Study 7847131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rTPA)
Number of subjects: 224
Study 2480626 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard protocol for refraction and visual acuity measurement
Number of subjects: 82
Study 1107462 — intervention group
Group type: COMPARATOR
Intervention: benperidol
Number of subjects: 12
Study 1107462 — intervention group
Group type: COMPARATOR
Intervention: chlorpromazine
Number of subjects: 12
Study 1107462 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 1107462 — intervention group
Group type: EXPERIMENTAL
Intervention: cyproterone acetate
Number of subjects: 12
Study 1107462 — intervention group
Group type: EXPERIMENTAL
Intervention: ethynyl oestradiol
Number of subjects: 12
Study 1107462 — intervention group
Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 12
Study 29493476 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives and traffic-light labels
Number of subjects: 148
Study 29493476 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial incentives or traffic-light labels)
Number of subjects: 148
Study 27299699 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT-based intervention (LIBER8)
Number of subjects: 45
Study 27299699 — intervention group
Group type: COMPARATOR
Intervention: Weight management group (2BFit)
Number of subjects: 45
Study 25436213 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 105
Study 25436213 — intervention group
Group type: COMPARATOR
Intervention: Carperitide
Number of subjects: 105
Study 22765277 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed counseling
Number of subjects: 2032
Study 22765277 — intervention group
Group type: COMPARATOR
Intervention: Standard care messages
Number of subjects: 2032
Study 20064838 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received counseling, nicotine patches, quit guide, plus information about cigarette characteristics
Number of subjects: 682
Study 20064838 — intervention group
Group type: COMPARATOR
Intervention: Control group received counseling, nicotine patches, quit smoking guide
Number of subjects: 682
Study 20064838 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 682
Study 20064838 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental materials
Number of subjects: 682
Study 18328868 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Family Systems Therapy for Diabetes (BFST‐D)
Number of subjects: 104
Study 18328868 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 104
Study 18328868 — intervention group
Group type: COMPARATOR
Intervention: Educational Support Group (ES)
Number of subjects: 104
Study 15882208 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroalcoholic mouthwash
Number of subjects: 30
Study 15882208 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-alcoholic mouthwash
Number of subjects: 30
Study 12698207 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (10 mg daily)
Number of subjects: 0
Study 12698207 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 0
Study 9925870 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with porcine surfactant (Curosurf)
Number of subjects: 60
Study 9925870 — intervention group
Group type: COMPARATOR
Intervention: Late treatment with porcine surfactant (Curosurf)
Number of subjects: 60
Study 8781630 — intervention group
Group type: COMPARATOR
Intervention: Oral thyrotrophin-releasing hormone (TRH) and placebo
Number of subjects: 19
Study 8781630 — intervention group
Group type: COMPARATOR
Intervention: Lithium and placebo
Number of subjects: 19
Study 8781630 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium and TRH
Number of subjects: 19
Study 1968726 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 25
Study 1968726 — intervention group
Group type: COMPARATOR
Intervention: Cromoglycate
Number of subjects: 25
Study 1968726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 369396 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate therapy
Number of subjects: 13
Study 369396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 31349965 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced caring communication style
Number of subjects: 148
Study 31349965 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced structuring communication style
Number of subjects: 148
Study 31349965 — intervention group
Group type: COMPARATOR
Intervention: Standard communication
Number of subjects: 148
Study 31349965 — intervention group
Group type: COMPARATOR
Intervention: Standard structuring
Number of subjects: 148
Study 29479010 — intervention group
Group type: COMPARATOR
Intervention: LDL-C target of < 2.07 mmol/L
Number of subjects: 400
Study 29479010 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C target of < 2.07 mmol/L and hs-CRP target of < 3 mg/L
Number of subjects: 400
Study 26965492 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml per day of orange juice (OJ) for 12 weeks
Number of subjects: 36
Study 26965492 — intervention group
Group type: COMPARATOR
Intervention: Energy and sugars-matched orange-flavoured drink (control)
Number of subjects: 36
Study 26965492 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml per day of orange juice (OJ)
Number of subjects: 36
Study 25151031 — intervention group
Group type: EXPERIMENTAL
Intervention: STAT: simvastatin, 40 mg/day
Number of subjects: 50
Study 25151031 — intervention group
Group type: EXPERIMENTAL
Intervention: EX: brisk walking and/or slow jogging, 45 minutes/day, 5 days/week
Number of subjects: 50
Study 25151031 — intervention group
Group type: EXPERIMENTAL
Intervention: STAT + EX
Number of subjects: 50
Study 25151031 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 50
Study 22822453 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk chocolate snack
Number of subjects: 90
Study 22822453 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate
Number of subjects: 90
Study 22822453 — intervention group
Group type: COMPARATOR
Intervention: Crackers with cheese spread (control)
Number of subjects: 90
Study 20228381 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (25 or 100 mg)
Number of subjects: 15
Study 20228381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17388768 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy acupressure
Number of subjects: 30
Study 17388768 — intervention group
Group type: COMPARATOR
Intervention: Acupressure
Number of subjects: 30
Study 16254086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergroup interaction
Number of subjects: 0
Study 16254086 — intervention group
Group type: COMPARATOR
Intervention: Within-group interaction
Number of subjects: 0
Study 12148173 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone (200 mcg twice daily)
Number of subjects: 37
Study 12148173 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil (0.004 g four times daily)
Number of subjects: 37
Study 10577402 — intervention group
Group type: EXPERIMENTAL
Intervention: Video self-instruction (VSI) in CPR for 34 minutes
Number of subjects: 0
Study 10577402 — intervention group
Group type: COMPARATOR
Intervention: Traditional CPR training (4-hour American Heart Association 'Heartsaver' CPR course)
Number of subjects: 0
Study 10577402 — intervention group
Group type: EXPERIMENTAL
Intervention: Video self-instruction (VSI)
Number of subjects: 0
Study 10577402 — intervention group
Group type: COMPARATOR
Intervention: Traditional CPR training
Number of subjects: 0
Study 8538079 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanji morphogram reading
Number of subjects: 9
Study 8538079 — intervention group
Group type: EXPERIMENTAL
Intervention: Kana syllabogram reading
Number of subjects: 9
Study 8538079 — intervention group
Group type: COMPARATOR
Intervention: Eyes open controls
Number of subjects: 9
Study 2015731 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole, 200 mg orally, daily for 14 days
Number of subjects: 20
Study 2015731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7278648 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol (1 mg, TID, po)
Number of subjects: 0
Study 7278648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31241782 — intervention group
Group type: EXPERIMENTAL
Intervention: Static computer‐assisted implant surgery (CAIS)
Number of subjects: 52
Study 31241782 — intervention group
Group type: COMPARATOR
Intervention: Freehand implant surgery
Number of subjects: 52
Study 27686365 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational treatment strategy
Number of subjects: 528
Study 27686365 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic treatment strategy
Number of subjects: 528
Study 26743237 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rate cut-off programming (Arm B)
Number of subjects: 1499
Study 26743237 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed ventricular tachycardia therapy programming (Arm C)
Number of subjects: 1499
Study 26743237 — intervention group
Group type: COMPARATOR
Intervention: CRT-D patients
Number of subjects: 1499
Study 26743237 — intervention group
Group type: COMPARATOR
Intervention: Both groups (ICD and CRT-D)
Number of subjects: 1499
Study 24150522 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver resection
Number of subjects: 52
Study 24150522 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 52
Study 24150522 — intervention group
Group type: COMPARATOR
Intervention: RFA
Number of subjects: 52
Study 22082694 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine HCl
Number of subjects: 60
Study 22082694 — intervention group
Group type: EXPERIMENTAL
Intervention: Proparacaine HCl
Number of subjects: 60
Study 22082694 — intervention group
Group type: EXPERIMENTAL
Intervention: TetraVisc
Number of subjects: 60
Study 18767129 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive recruitment (face‐to‐face)
Number of subjects: 249
Study 18767129 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive recruitment (television, radio, or newspaper ads)
Number of subjects: 249
Study 18767129 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination recruitment (both reactive and proactive)
Number of subjects: 249
Study 17660602 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF, or filgrastim) 300 mcg s/c weekly
Number of subjects: 47
Study 17660602 — intervention group
Group type: COMPARATOR
Intervention: Interferon dose reduction or temporary inhibition of Interferon treatment
Number of subjects: 47
Study 15876831 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux membranes
Number of subjects: 0
Study 15876831 — intervention group
Group type: COMPARATOR
Intervention: Conventional low-flux dialysis
Number of subjects: 0
Study 11988189 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery wall thickness (WT) in patients with CAD (0.4 +/- 0.05 mm)
Number of subjects: 179
Study 11988189 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery wall index (WI) in patients with CAD (16.1 +/- 0.0)
Number of subjects: 179
Study 11988189 — intervention group
Group type: EXPERIMENTAL
Intervention: WT and WI correlation with CAD presence
Number of subjects: 179
Study 9607671 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional brace
Number of subjects: 85
Study 9607671 — intervention group
Group type: COMPARATOR
Intervention: Dorso‐ulnar plaster‐of‐Paris
Number of subjects: 85
Study 9607671 — intervention group
Group type: COMPARATOR
Intervention: Elastic bandage
Number of subjects: 85
Study 8151107 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA (600 mg/day)
Number of subjects: 60
Study 8151107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3524728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphamethoxazole 2 g daily for 3 months
Number of subjects: 23
Study 3524728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 26672090 — intervention group
Group type: EXPERIMENTAL
Intervention: HbSS (Walk‐PHaSST Trial)
Number of subjects: 463
Study 26672090 — intervention group
Group type: COMPARATOR
Intervention: HbSC (Walk‐PHaSST Trial)
Number of subjects: 463
Study 26672090 — intervention group
Group type: COMPARATOR
Intervention: CSSCD
Number of subjects: 463
Study 25230733 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin combined with Tiao Jing Cu Yun pills
Number of subjects: 78
Study 25230733 — intervention group
Group type: COMPARATOR
Intervention: Letrozole alone (Control)
Number of subjects: 78
Study 22169113 — intervention group
Group type: EXPERIMENTAL
Intervention: MBX-8025 (50 mg/d)
Number of subjects: 166
Study 22169113 — intervention group
Group type: EXPERIMENTAL
Intervention: MBX-8025 (100 mg/d)
Number of subjects: 166
Study 22169113 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 166
Study 22169113 — intervention group
Group type: EXPERIMENTAL
Intervention: MBX-8025 (100 mg/d) + Atorvastatin (20 mg/d)
Number of subjects: 166
Study 20307706 — intervention group
Group type: COMPARATOR
Intervention: mebeverine
Number of subjects: 149
Study 20307706 — intervention group
Group type: EXPERIMENTAL
Intervention: mebeverine+CBT
Number of subjects: 149
Study 17942379 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions from randomized controlled clinical trials on GERD
Number of subjects: 0
Study 17942379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17942379 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies evaluated in trials
Number of subjects: 0
Study 17942379 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up data
Number of subjects: 0
Study 16254540 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention group
Number of subjects: 427
Study 16254540 — intervention group
Group type: COMPARATOR
Intervention: Basic group
Number of subjects: 427
Study 11903465 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) administered at 18 mg/kg as an intravenous intraoperative load, followed by daily doses to maintain serum PHT concentrations within the 10-20 aeg/ml range for 7 days.
Number of subjects: 200
Study 11903465 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PHT administered).
Number of subjects: 200
Study 11903465 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) group.
Number of subjects: 200
Study 11783155 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI) combined with western medicine
Number of subjects: 60
Study 11783155 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone (Control)
Number of subjects: 60
Study 7861515 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic lymphocelectomy (group 1)
Number of subjects: 38
Study 7861515 — intervention group
Group type: COMPARATOR
Intervention: Open lymphocelectomy (group 2)
Number of subjects: 38
Study 7861515 — intervention group
Group type: COMPARATOR
Intervention: Historical open lymphocelectomy (group 3)
Number of subjects: 38
Study 1827810 — intervention group
Group type: EXPERIMENTAL
Intervention: diatrizoate (ionic, high osmolality)
Number of subjects: 30
Study 1827810 — intervention group
Group type: EXPERIMENTAL
Intervention: ioxaglate (ionic, low osmolality)
Number of subjects: 30
Study 1827810 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol (nonionic, low osmolality)
Number of subjects: 30
Study 7001242 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol (DES)
Number of subjects: 143
Study 7001242 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 143
Study 31133672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment with dihydroartemisinin-piperaquine (IST-DP)
Number of subjects: 681
Study 31133672 — intervention group
Group type: COMPARATOR
Intervention: Intermittent preventive therapy with sulfadoxine-pyrimethamine (IPT-SP)
Number of subjects: 681
Study 28410008 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise carious tissue removal
Number of subjects: 239
Study 28410008 — intervention group
Group type: COMPARATOR
Intervention: Nonselective carious removal to hard dentin
Number of subjects: 239
Study 28410008 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulp-capping procedures (direct pulp capping or partial pulpotomy)
Number of subjects: 239
Study 26393848 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-focused text messaging (4 messages/week for 6 months)
Number of subjects: 710
Study 26393848 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 710
Study 24195872 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP treatment for 2 or 3 preoperative nights and 5 postoperative nights.
Number of subjects: 177
Study 24195872 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving routine care.
Number of subjects: 177
Study 21208974 — intervention group
Group type: EXPERIMENTAL
Intervention: RLY5016 (30 g/day)
Number of subjects: 105
Study 21208974 — intervention group
Group type: EXPERIMENTAL
Intervention: RLY5016 (30 g/day) in patients with CKD
Number of subjects: 105
Study 21208974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 19844579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program aimed at health promotion or disease prevention
Number of subjects: 0
Study 19844579 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 17900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group intervention (8 weekly sessions of 2 hours each, plus a booster session after 6 months)
Number of subjects: 168
Study 17900336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group intervention
Number of subjects: 168
Study 15021192 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin for the prevention and treatment of patent ductus arteriosus
Number of subjects: 0
Study 15021192 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic or surgical methods to close the ductus arteriosus
Number of subjects: 0
Study 11899912 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microg/cm2 of TGF‐beta3
Number of subjects: 14
Study 11899912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 microg/cm2 of TGF‐beta3
Number of subjects: 14
Study 11899912 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 14
Study 9764446 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking training (65-75% of VO2max, 50 min/session, four times a week for 15 weeks)
Number of subjects: 119
Study 9764446 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study 10163540 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple donor non‐apheresis buffy coat platelets (BCP)
Number of subjects: 0
Study 10163540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single donor apheresis platelets (SDP)
Number of subjects: 0
Study 10163540 — intervention group
Group type: EXPERIMENTAL
Intervention: Single donor leucodepleted SDP (LD‐SDP)
Number of subjects: 0
Study 2655452 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasil (ethinyl estradiol/levonorgestrel)
Number of subjects: 0
Study 2655452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 7/7/7 (ethinyl estradiol/norethindrone)
Number of subjects: 0
Study 826928 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M-P (no undrugged practice before marijuana intoxication)
Number of subjects: 2
Study 826928 — intervention group
Group type: EXPERIMENTAL
Intervention: Group P-M (undrugged practice before marijuana intoxication)
Number of subjects: 2
Study 826928 — intervention group
Group type: COMPARATOR
Intervention: Control measures (pulse rate, salivary flow, subjective responses)
Number of subjects: 2
Study 31895058 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based treatment
Number of subjects: 19
Study 31895058 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral usual treatment
Number of subjects: 19
Study 31518058 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day ART initiation
Number of subjects: 536
Study 28221060 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program (CHP) - yearlong afterschool program
Number of subjects: 216
Study 28221060 — intervention group
Group type: COMPARATOR
Intervention: Comparable control participants (community care)
Number of subjects: 216
Study 25176010 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (1.3 g twice daily for 3 weeks)
Number of subjects: 13
Study 25176010 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation
Number of subjects: 13
Study 23674344 — intervention group
Group type: EXPERIMENTAL
Intervention: Telomere length (continuous variable, reported per 0.2 unit increase)
Number of subjects: 853